Get started

Covid-2019

Long biased w/ recent settlement with Apotex and tight range.21-May-20 16:10 ET AMRN Amarin announces trial to evaluate effects of VASCEPA on patients with COVID-19 (7.28 -0.18) Amarin today announced support for a clinical trial to investigate the effects of icosapent ethyl (IPE) (VASCEPA) on inflammatory biomarkers and other patient outcomes in individuals with COVID-19. The trial primary endpoint is the effect of VASCEPA versus usual care on high-sensitivity C-reactive protein levels from baseline to 14 days in adults with a COVID-19-positive diagnosis. The clinical study design also includes other endpoints that assess rates and severity of COVID-19 infection in this high-risk group. The company states, "Based on our current understanding of the biological effects of a COVID-19 infection, including that patients at high risk of cardiovascular disease are at higher risk of mortality and severe effects from a COVID-19 infection, and based on data related to the mechanism of action and effects of VASCEPA in lowering cardiovascular risk in certain high-risk patients, it is believed that VASCEPA could play a beneficial clinical role in helping patients infected by the virus." 14-May-20 14:52 ET AMRN Amarin announces VASCEPA data from prespecified and post hoc analyses of REDUCE-IT study (7.64 +0.22) Amarin today announced that data from the REDUCE-IT study presented at the Society for Cardiovascular Angiography & Interventions 2020 Scientific Sessions,showed that administration of 4 g/day of VASCEPA (icosapent ethyl) resulted in a significant 34% reduction in first coronary revascularizations versus placebo (p<0.0001). Similar reductions of 36% were observed in total, or first and subsequent, revascularizations (p<0.0001). The analyses from the REDUCE-IT study included several types of coronary revascularization events in statin-treated patients with persistent elevated triglycerides (135-499 mg/dL), who also had either cardiovascular disease or diabetes and additional cardiovascular risk factors. Prespecified tertiary endpoint analyses showed that times to first revascularization events were significantly reduced by VASCEPA versus placebo across subtypes of intervention, including urgent, emergent, and elective revascularizations, which were reduced by 34% (p<0.0001), 38% (p=0.02), and 32% (p<0.0001), respectively. In post hoc analyses, VASCEPA significantly reduced percutaneous coronary intervention (PCI) by 32% (p<0.0001) and coronary artery bypass grafting (CABG) by 39% relative to placebo (p=0.0005).
NASDAQ:AMRNLong
by SwingingForward
Z1P : 20% BREAK INCOMING! ZIP CO LIMITED (ASX:Z1P) has bounced back significantly well after the market dump in FEB/MAR, as have all lending services due to the job losses/ government surpluses around the world. When the market reopens on monday I can see a couple of things happening. 1: WE crack this 'strong equilibrium' as price action continues up the trendline and get squeezed into the corner, 20% TARGET - Respecting Uptrend - Buyer Volume Present -Covid19 crisis still taking a toll on the economy (People still borrowing) If we do break the equilibrium my next target would be the 4.14 Equilibrium. Careful though as 'Bearish Divergence' could follow. 2: The Resistance holds and we break trend, returning to 'Previous Support' 10% TARGET -Uptrend Trendline Breaks -Double Top Confirms -MACD crosses -.236 Fib Breaks 3: Previous Support Fails and we fall to 2.84 Support. 15% TARGET -Breaks .236 & .382 Fibs -Healthy Retrace after 230% move -MACD will have crossed -Center BB will have failed NOTE: There is an OPEN GAP sitting inside the 'Golden Pocket'. Do not be surprised if we see this fill. Offering simple interest free and flexible repayment options, Strong Retail Affiliations and having an App in the Top 10 of Google Play and Apple, it's easy to see why Z1P is doing so well. They are up $45Million in revenue and have nearly cracked 2 Million Users. These Ideas are NOT 'Financial Advice'!. Scenarios are based off a mixture of TA and Fundamentals current at the time. All IMO GLTAH. Happy Hunting!!!
ASX:ZIP
by Trader_Johnni
1
COVID-19 France confirmed/recovered/deathsI would like to know someone who studied normalized Gaussian curves with expected value u and variance o2. In theory, the more we will test people, the more the curve will spike rapidly, to go down rapidly, but it's just mathematics, not epidemiology. According to epidemiologists, there won't be second wave before September 2020. Here is the official numbers according to the Regional Health Agency : dashboard.covid19.data.gouv.fr 160 750 confirmed cases Reduction in confirmed cases due to a change in calculation method. Since June 2, patients who test positive are only counted once. 29 663 deaths 9 693 hospitalizations 74 612 returns to home 701 in reanimation 19 206 deaths at hospital 37 901 confirmed cases in retirement house and medical social establishment 10 457 deaths in retirement house and medical social establishment
CEducation
by Nugacity_Fracedinous
TA meets speculative fundamental analysis on SPYSince the "V-shaped" recovery started, we've seen nothing but divergence. It's mostly speculation, but me and many other people believe this volatile bull run since the start of the COVID-19 crisis is almost solely because of the FED blindly pumping money into securities. While that money is not running out anytime soon, we're seeing a significant volume and momentum slowdown in the last two to three weeks. RSI is the only thing that is not diverging even though the average SRSI is lower recently (the last 2-3 weeks). More speculation: Multiple news sources are reporting investors becoming more cautious of a "second wave" or "second peak" of the corona virus. I personally believe it's virtually inevitable in the US at least. Here's why: 1) Protests for civil rights have caused thousands of people to gather closely for extended periods of time across weeks (shouting chants and contacting each other directly). Even with masks and other PPE, this presents a great risk of virus propagation. 2) Most states have reopened/partially reopened increasing the amount of contact to the public workers and patrons have. Even with SOME states implementing strict restrictions on the reopening, this presents a great risk of virus propagation, not to mention it has already caused an uptick in the daily new cases within the US. 3) Developing and 3rd world countries are seeing their own first peak in cases. This is driving the record daily new cases across the world we saw yesterday of 146,111 new cases. The record before that was the 6/16 with 143,566 new cases. The record before that was 6/12 with 143,421. (Data provided from worldometers.com) As TA would say, new higher highs with an exponentially increasing moving average would say greater numbers are to come. So while this bull run could continue for a relatively short period of time (2-3 more weeks), all signs point to a significant pull back that the FED will not be able to revert without significant fiscal policy. This analysis along with the inverted yield curve, dramatic reduction in consumer spending, dramatic increase in unemployment, and much more, cause me to be conservatively switching back to a bear market strategy across my portfolio.
AMEX:SPYShort
by ImAstronaut
3
Heat Biologics HTBX is working on the Covid-19 vaccineHeat Biologics HTBX is one of the lowest market cap companies (65.51M) working on the Covid-19 vaccine. It has a lot of room to grow from it`s peak in Oct 4th 2013 (139,90 usd) The indiccators are also showing a strong buying power. Heat Biologics Inc. HTBX has previously announced that it is developing a vaccine for the novel coronavirus with the University of Miami Miller School of Medicine. It disclosed March 17 in a financial filing that its COVID-19 vaccine candidate had been added to the World Health Organization’s “draft landscape” of 41 candidate vaccines. The company also recently joined the Alliance for Biosecurity, which may help it “secure government funding to support its rapid development, production, and distribution” of its COVID-19 vaccine, according to Maxim Group analysts.
HLong
by TopgOptions
2
History Repeats Itself: Those Who Do Not Learn History Are Doomed To Repeat It. Second wave of virus coming even though Fauci says is still wave 1. Everything is setup for another bear market, and when Robinhooders start to loose money for their bull positions, they with turn sides and give strenght to bear market like a Domino Effect. Vix touched bottom on 24.50 and S&P500 futures touched their peak on 3230. Is a bubble inside another bubble. Buying stocks of collapsed companies, is no good idea... bubbles DO break! Fear has been evident for the last 1 and a half week.
OANDA:SPX500USDShort
by PinkyyCerebro
Covid related stock may skyrocket soon (HAPP, LONG)Soon, Earnings Report. Very good risk/reward ratio. Strong sentiment for this stock generally. Considered as a gem by many. Why? Macro-context: Threat of a second COVID wave. Fundamentals: Very strong ROCE (Happiness Biotech Group's ROCE is meaningfully higher than the 21% average in the Personal Products industry. ) Source:https://finance.yahoo.com/news/happiness-biotech-group-limited-nasdaq-115758706.html Sales: "Happiness Biotech Reports Monthly Online Sales Growth of 694%" Source:https://finance.yahoo.com/news/happiness-biotech-reports-monthly-online-120000206.html Innovation: "Happiness Biotech Announced Breakthrough in Developing Covid-19 Testing Kits" Source: finance.yahoo.com "Happiness Biotech Started Exporting Disposable Hand Sanitizer" Source:https://finance.yahoo.com/news/happiness-biotech-started-exporting-disposable-120000307.html Why not hype before? Simply because it was an unknown pre-covid and because it didn't have traction while investors were focused on post-covid momentum. The company took COVID as opportunity to develop. This stock may get so
HLong
by UnknownUnicorn4700255
Break current triangle followed by lengthened market cycleLooking at logarithmic progressions has me thinking that it might be possible that we find support on the line we just broke followed by establishing a slightly higher high followed by undulating smaller pump/dumps that correlate with past events. We form a new upper resistance and therefore a new structure, we break out of this 4-5 years down the road. The market cycles are going to level out as time goes on in terms of highs and lows resulting in a more stable coin IF BTC doesnt become obsolete before then. I think this summer could be good for BTC and the market. Economy will open up, containment of virus will differ depending on country/state/province. Summer usually knocks case numbers down for respiratory illness due to high temps, humidity, and elevated levels of vitamin D, physical activity, spending more times in open spaces. Offices also won't be in a hurry to open back up due to the inability for them to justify moving admin and other office worker resources back into huge office buildings when they can just as easily work from home. Also, the logistics in using elevators, lobbies, and other areas while maintaining any level of social distance is extremely daunting and expensive. I think these factors will result in a less "spready" second wave. This adds up to the irrational, illogical market continuing to pump over the summer. The second COVID wave , in the fall/winter will likely bring another market correction with it, which will drag BTC with it. Also, ppl are on the media at these protests yelling "buy BTC, fight the power" at the camera, any publicity is good publicity, I guess. Summer=Pump, Fall/winter = Dump and or consolidation I think we'll continue to undulate, consolidate, slowly ascend into breaking a larger, future structure. Big, rambly, speculative, but I think a lot of what happens in all markets will be the result of COVID and COVID related responses from govs/industry. These are sort of predictable based on what we know about similar viruses and how govs and market has responded up until now. Whatcha think?
BITSTAMP:BTCUSDLong
by Tobi_Wan_Kenobi
Delta Airlines Post COVID 19 thoughts June 2020If looked from the perspective of Fibonacci... chances are DAL prices during COVID 19 align with a 78% retrace line. Those also seem to match resistance around the initial trading values of this stock. There is a good chance that during June and follow on months, this price will continue to grow and test the $50 price. At least from my perspective. Whether if it only tests the $50 to later come back down or just go back to previous price ranges, there may be a profit benefit here. The next months behavior really depends on what is going to happen around the Pandemic itself and associated travel restrictions. As well as how humans may fear traveling in the short term. It seems that a buy at current price range may reward with short term growth. If it happens, it can potentially be protected with a sell limit in case prices fall again. Another strategy may be to buy and just sell with the price hits the $50 range. It'll all depend on each individual's preference: Do you want the shares for the long term (and take advantage of current bargain prices)?; Or do you want to profit with volatility?
NYSE:DAL
by Aizakku
5
BBY: $88 Short Target because Post-Covid Shopping + DemandFirst off, please don't take anything I say seriously or as financial advice. As always, this is on an opinion based basis. That being said, I have a few insights. Best Buy is expected to have a positive continuation of its recent uptrends, and I have it on my watchlist. Currently, I am bullish on the supply and demand curve getting fixated and that it could hit an $88 price target quite soon. I also think it has some long potential as well, so I am ranking this a long.
NYSE:BBYLong
by gamer456148